Regulation and Cellular Functions of V-ATPases

V-ATP酶的调节和细胞功能

基本信息

  • 批准号:
    10405829
  • 负责人:
  • 金额:
    $ 52.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2027-03-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY V-ATPases are versatile, highly conserved, multi-subunit proton pumps responsible for organelle acidification in virtually all eukaryotic cells. Complete loss of V-ATPase activity is lethal in all eukaryotes except fungi, but mutations in subunit isoforms are linked to distal renal tubule acidosis, infertility, deafness, and osteopetrosis. V-ATPase activity is subverted in cancer to support additional demands on cellular pH homeostasis and promote metastasis by creating an acidic extracellular environment. Endosomal acidification by V-ATPases also promotes entry of many viruses. There is a crucial need to understand the roles and regulation of V- ATPase subunit isoforms and enzyme subpopulations in order to target of V-ATPases in specific locations therapeutically. V-ATPases are regulated by reversible disassembly of the peripheral V1 subcomplex from the integral membrane Vo subcomplex, and RAVE/Rabconnectin-3 complexes play a critical role in this process. We will investigate the structure, mechanism, and subunit composition of the yeast RAVE and mammalian Rabconnectin-3 complexes, which appear to target specific V-ATPase subunit isoforms as part of their activity. Importantly, mutations in Rabconnectin-3 complexes have been associated with epilepsy and neurodegeneration but the underlying disease mechanism is unclear. We previously demonstrated in yeast that organelle-enriched phosphoinositide phospholipids bind differentially to the two a-subunit isoforms of the Vo subcomplex, providing organelle-specific inputs into V-ATPase localization and activity. Similar lipid interactions are observed with mammalian a-subunit isoforms in vitro, and we will extend these studies to characterizing the effects of the interactions in cultured mammalian cells. Finally, although V-ATPases must function in concert with other cellular mechanisms of pH homeostasis, the underlying mechanisms of this coordination are not understood. We will address this question in yeast, where we have discovered that acute or chronic loss of V-ATPase activity triggers endocytosis of a portion of the major H+ export pump, Pma1, from the plasma membrane. We will determine the mechanism of this vacuole to plasma membrane pH crosstalk. Reduced vacuole/lysosome acidification is an early step in aging in both yeast and mammalian cells. We will assess whether aging yeast cells display a loss in coordinated pH homeostasis or emerging defects in the V- ATPase itself and determine whether these processes can be manipulated.
项目总结 V-ATPase是一种多功能、高度保守的多亚单位质子泵,负责细胞器的酸化 在几乎所有的真核细胞中。V-ATPase活性的完全丧失在除真菌以外的所有真核生物中都是致命的,但 亚基异构体的突变与远端肾小管酸中毒、不孕症、耳聋和骨化症有关。 V-ATPase活性在癌症中被颠覆,以支持对细胞pH动态平衡的额外需求 通过创造酸性的细胞外环境来促进转移。V-ATPase引起的内体酸化 也促进了许多病毒的进入。我们迫切需要了解V-的作用和调节。 靶向V-ATPase的ATPase亚基亚型和酶亚群 从治疗上讲。V-ATPase由外周V1亚复合体的可逆解离调节 整体膜Vo亚复合体和RAVE/RabConnectin-3复合体在这一过程中起着关键作用。 我们将研究酵母狂欢和哺乳动物的结构、机制和亚基组成。 RabConnectin-3复合体,它似乎以特定的V-ATPase亚单位亚基为靶标作为其活性的一部分。 重要的是,RabConnectin-3复合体的突变与癫痫和 神经退化,但潜在的疾病机制尚不清楚。我们之前在酵母菌中展示了 富含细胞器的磷脂酰肌醇与两种α-亚基的不同结合。 VO亚复合体,为V-ATPase的定位和活性提供细胞器特异性的输入。类脂 在体外观察到与哺乳动物a亚基异构体的相互作用,我们将把这些研究扩展到 描述在培养的哺乳动物细胞中相互作用的影响。最后,尽管V-ATPase必须 与pH动态平衡的其他细胞机制协同作用,其潜在机制 协调是不被理解的。我们将在酵母中解决这个问题,我们在那里发现了急性 或V-ATPase活性的慢性丧失触发主要H+输出泵Pma1的一部分内吞作用 质膜。我们将确定这个液泡对质膜pH串扰的机制。 减少的空泡/溶酶体酸化是酵母和哺乳动物细胞衰老的早期阶段。我们会 评估老化的酵母细胞是否表现出协调pH动态平衡的丧失或V- ATPase本身,并确定这些进程是否可以被操纵。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PATRICIA M KANE其他文献

PATRICIA M KANE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PATRICIA M KANE', 18)}}的其他基金

Regulation and Cellular Functions of V-ATPases
V-ATP酶的调节和细胞功能
  • 批准号:
    10593953
  • 财政年份:
    2022
  • 资助金额:
    $ 52.43万
  • 项目类别:
Regulation of V-ATPases by Phosphoinositides
磷酸肌醇对 V-ATP 酶的调节
  • 批准号:
    10162616
  • 财政年份:
    2018
  • 资助金额:
    $ 52.43万
  • 项目类别:
Molecular & Cellular Bioenergetics Gordon Conf. 2005
分子
  • 批准号:
    6934864
  • 财政年份:
    2005
  • 资助金额:
    $ 52.43万
  • 项目类别:
A Skpl-containing Complex Regulating V-ATPase Activity
含 Skpl 的调节 V-ATP 酶活性的复合物
  • 批准号:
    6474326
  • 财政年份:
    2002
  • 资助金额:
    $ 52.43万
  • 项目类别:
A Skpl-containing Complex Regulating V-ATPase Activity
含 Skpl 的调节 V-ATP 酶活性的复合物
  • 批准号:
    6927940
  • 财政年份:
    2002
  • 资助金额:
    $ 52.43万
  • 项目类别:
A Skpl-containing Complex Regulating V-ATPase Activity
含 Skpl 的调节 V-ATP 酶活性的复合物
  • 批准号:
    6608539
  • 财政年份:
    2002
  • 资助金额:
    $ 52.43万
  • 项目类别:
A Skpl-containing Complex Regulating V-ATPase Activity
含 Skpl 的调节 V-ATP 酶活性的复合物
  • 批准号:
    6777579
  • 财政年份:
    2002
  • 资助金额:
    $ 52.43万
  • 项目类别:
Subunit Structure and Function in Vacuolar H+-ATPase
液泡 H-ATP 酶的亚基结构和功能
  • 批准号:
    6752136
  • 财政年份:
    1994
  • 资助金额:
    $ 52.43万
  • 项目类别:
Subunit Structure and Function in Vacuolar H+-ATPases
液泡 H-ATP 酶的亚基结构和功能
  • 批准号:
    8330154
  • 财政年份:
    1994
  • 资助金额:
    $ 52.43万
  • 项目类别:
Subunit Structure and Function in Vacuolar H+-ATPase
液泡 H-ATP 酶的亚基结构和功能
  • 批准号:
    7068127
  • 财政年份:
    1994
  • 资助金额:
    $ 52.43万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.43万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了